Software - ANVISA Registration 81414021713

Access comprehensive regulatory information for Software in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 81414021713 and manufactured by MYSUGR GMBH. The registration is held by ROCHE DIABETES CARE BRASIL LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including PHILIPS MEDICAL SYSTEMS NEDERLAND B.V., CARDIO SISTEMAS COMERCIAL E INDUSTRIAL LTDA, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
81414021713
Registration Details
ANVISA Registration Number: 81414021713
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

DIÁRIO MYSUGR
Risk Class II

Registration Details

81414021713

25351560734202127

23552212000187

Company Information

MYSUGR GMBH
Austria
PT: ÁUSTRIA

Dates and Status

Oct 28, 2021

VIGENTE

09/18/2025 19:00:01